Authors

• Alexander Egeberg (ORCID: https://orcid.org/0000-0001-8257-1816)
• Jacob Pontoppidan Thyssen (ORCID: https://orcid.org/0000-0003-3770-1743)
• Simon Francis Thomsen (ORCID: https://orcid.org/0000-0002-4838-300X)
• Emma Guttman‐Yassky (ORCID: https://orcid.org/0000-0002-9363-324X)
• Christoph Schlapbach (ORCID: https://orcid.org/0000-0003-0258-1243)
• Maria Oberländer Christensen (ORCID: https://orcid.org/0000-0001-7177-1054)
• Khaled Ezzedine (ORCID: https://orcid.org/0000-0002-5468-4589)
• Lea K. Nymand (ORCID: https://orcid.org/0000-0001-7202-0607)
• Claus Zachariae (ORCID: https://orcid.org/0000-0001-5506-1319)
• Sonja Molin (ORCID: https://orcid.org/0000-0002-9383-034X)
• Johan Sieborg (ORCID: https://orcid.org/0000-0002-8221-4760)
• Jianzhong Zhang

Institutions

• University of Bern (CH)
• University of Copenhagen (DK)
• Université Paris-Est Créteil (FR)
• Peking University (CN)
• Queen's University (CA)
• University Hospital of Bern (CH)
• Frederiksberg Hospital (DK)
• Gentofte Hospital (DK)
• Peking University People's Hospital (CN)
• Icahn School of Medicine at Mount Sinai (US)

Publication Details

Journal

Journal of the American Academy of Dermatology

Published

2024-08-23

DOI

https://doi.org/10.1016/j.jaad.2024.07.1503

Citations

12

Primary Topic

Contact Dermatitis and Allergies

Type

article

Field-Weighted Citation Impact

6.42

Funders

• Amgen
• Bristol-Myers Squibb
• National Psoriasis Foundation
• Eli Lilly and Company
• Pfizer
• Sanofi
• Regeneron Pharmaceuticals
• Kongelig Hofbuntmager Aage Bangs Fond
• Simon Spies Fonden
• LEO Pharma
• Janssen Pharmaceuticals